Apoptosis, which is triggered by si-Ascl2 (small/short interference), could be counteracted by treatment with autophagy inhibitors, such as 3-methyladenine (3-MA) and chloroquine (CQ), indicating that Ascl2 targeted therapy may represent a new strategy for the treatment of CRC. Here, ASCL2 is linked to colorectal carcinoma.